• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

辛开苦降法治疗伊立替康所致延迟性腹泻经验浅析

通讯作者: 陈曦, fuzhoucxi@qq.com
DOI:10.12201/bmr.202601.00024
声明:预印本系统所发表的论文仅用于最新科研成果的交流与共享,未经同行评议,因此不建议直接应用于指导临床实践。

An Analysis of the Experience in Treating Irinotecan-Induced Delayed Diarrhea with the Method of Acrid Opening and Bitter Descending

Corresponding author: Chen Xi, fuzhoucxi@qq.com
  • 摘要:伊立替康是治疗肿瘤的常用化疗药物,其所致腹泻是临床常见的剂量限制性毒性反应,严重影响治疗进程与患者生存质量。本病可归属于中医“泄泻”、“下利”范畴。吾师陈曦主任长期致力于中西医结合肿瘤临床与研究,认为本病核心病机在于癌毒内耗与药毒外袭二者相兼为患,导致脾胃虚弱,枢机失运,清浊不分而发为泄泻;其证多属寒热错杂、虚实互见。本文旨在浅析陈师运用辛开苦降法治疗此症的经验,并分享一例运用半夏泻心汤斡旋中焦气机、平调寒热、补泻兼施,成功治疗伊立替康所致腹泻的验案,以期为临床辨治此类并发症提供借鉴与思路。

    关键词: 伊立替康腹泻辛开苦降法半夏泻心汤

     

    Abstract: Irinotecan is a commonly used chemotherapeutic agent for the treatment of tumors, and the diarrhea it induces is a frequent dose-limiting toxicity in clinical practice, significantly impacting the treatment process and the quality of life of patients. This condition can be categorized under the traditional Chinese medicine (TCM) concepts of diarrhea and dysentery. Professor Chen Xi, who has long been dedicated to the clinical practice and research of integrated Chinese and Western medicine in oncology, posits that the core pathogenesis of this condition lies in the combined effects of internal consumption by cancer toxins and external assault by drug toxins, leading to spleen-stomach deficiency, impaired pivot mechanism, and the separation of the clear and turbid, resulting in diarrhea. The syndrome is often characterized by a mixture of cold and heat, as well as deficiency and excess. This article aims to provide a brief analysis of Professor Chens experience in treating this condition with the method of acrid opening and bitter descending, and to share a successful case where Banxia Xiexin Decoction was used to regulate the middle burner qi mechanism, balance cold and heat, and simultaneously tonify and purge, effectively treating Irinotecan-induced diarrhea. This case is intended to offer insights and approaches for the clinical differentiation and treatment of such complications.

    Key words: Irinotecan; Diarrhea; Method of Acrid Opening and Bitter Descending; Banxia Xiexin Decoction

    提交时间:2026-01-09

    版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
  • 图表

  • 任志源, 陈婕, 杨舒月. 基于“治中焦如衡”探讨半夏泻心汤治疗功能性消化不良的作用机制. 2025. doi: 10.12201/bmr.202508.00032

    宋瑾婷, 付烊, 康朔麟, 刘晓平. 基于“寒热错杂”理论探析化疗相关腹泻的经方辨治. 2025. doi: 10.12201/bmr.202512.00010

    陈芳, 范晓良. 基于中医传承辅助平台的《理瀹骈文》膏药法用药规律分析. 2025. doi: 10.12201/bmr.202504.00072

    武文青, 宋思梦, 王释亮, 伍大华, 谢乐. 周慎教授基于“阴损及阳”理论从肝肾论治迟发性运动障碍经验. 2025. doi: 10.12201/bmr.202509.00038

    吴建奇, 黄鸿鹏, 林燕婷, 李寿杰, 陈晓聪. 从逐瘀化饮法辨治恶性腹水经验. 2025. doi: 10.12201/bmr.202503.00011

    张安安, 张锦梅, 胡丹丹. Paxlovid致迟发性药物性肝损1例并文献分析. 2025. doi: 10.12201/bmr.202502.00033

    陈佳慧, 陈 颜. 基于气机升降理论探讨反流性食管炎证治. 2025. doi: 10.12201/bmr.202507.00061

    王婷, 常亚辉, 秦祖杰, 王成龙, 张萌, 曹阳梦, 邓思炎. 基于数据挖掘的虚劳病用药规律及临床经验分析. 2025. doi: 10.12201/bmr.202507.00063

    范苗, 姚佳琪. 半量替格瑞洛治疗ACS患者PCI术后的综合评价. 2024. doi: 10.12201/bmr.202407.00070

    凌振伟, 吴子辉, 卢林涛, 柯亮, 袁芳, 王凯华. 基于数据挖掘探讨吴子辉治疗失眠的处方规律. 2025. doi: 10.12201/bmr.202504.00009

  • 序号 提交日期 编号 操作
    1 2025-11-24

    10.12201/bmr.202601.00024V1

    下载
  • 公开评论  匿名评论  仅发给作者

引用格式

李灵冰, 陈新潮, 陈曦. 辛开苦降法治疗伊立替康所致延迟性腹泻经验浅析. 2026. biomedRxiv.202601.00024

访问统计

  • 阅读量:50
  • 下载量: 0
  • 评论数:0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误